The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations

Metastatic melanoma is frequently fatal. Optimal treatment regimens require both rapid and durable disease control, likely best achieved by combining targeted agents with immunotherapeutics. In order to accomplish this, a detailed understanding of the immune consequences of the kinase inhibitors use...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Vella, Laura J, Andrews, Miles C, Pasam, Anupama, Woods, Katherine, Behren, Andreas, Cebon, Jonathan S
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2014
Matèries:
Author's View
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292757/
https://ncbi.nlm.nih.gov/pubmed/25610732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.946367
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars